左进胸微创多支冠状动脉搭桥术治疗冠心病的临床应用

目的 评价分析左进胸微创多支冠状动脉搭桥术(minimally invasive cardiac surgery for coronary artery bypass grafting,MICS CABG)治疗冠心病的效果及其可行性和安全性.方法 选取自2020年4月至2021年3月以来于中国科学技术大学附属第一医院开...

Clinical application of minimally invasive cardiac surgery for coronary artery bypass grafting through left thoracotomy in the treatment of coronary heart disease

Objective To evaluate the efficacy, feasibility and safety of minimally invasive cardiac surgery for coronary artery bypass grafting (MICS CABG) through left thoracotomy in the treatment of multi-vessel coronary artery disease.Methods Retrospectiveanalysis was performed on 10 patients with coronary artery disease who underwent MICS CABG in The First Affiliated Hospital of University of Science and Technology of China from April 2020 to March 2021. The preoperative basic information, intraoperative datasuch as bypass number, postoperative data and complications of patients were analyzed to evaluate the effect and feasibility of MICSCABG.Results A total of 23 grafts were performed in 10 patients who underwent MICS CABG with an average of 2.3 grafts per person. There was no person transferred to midline thoracotomy or performed intra-aortic balloon pump(IABP). All patients were transferred to the intensive care unit(ICU) for treatment after surgery with no second operation performed. The median postoperative ventilator time was 9 h, and the median ICU time was 47.75 h. The median drainage volume on the first day after surgery was 275 mL, and 3patients (30%) received blood transfusion. No atrial fibrillation, renal function impairment, major adverse cardiovascular events, postoperative death or postoperative cerebral infarction occurred during hospitalization. The median postoperative hospital stay was 9.5 days.Conclusion MICS CABG is a safe and effective therapy for coronary artery disease with good prognosis for appropriate patient withfine perioperative management.